Skip to main content
. 2022 Nov 24;10(12):2002. doi: 10.3390/vaccines10122002

Figure 1.

Figure 1

Flowchart showing recruitment and participant selection. The blood specimens were collected at multiple time points following vaccination. The second dose of the vaccine was of the same vaccine type (homologous). n indicates number and * Denotes participants who didn’t report previous infection in the survey but gave positive IgG titer indicating previous undiagnosed SARS-COV-2 infection.